Literature DB >> 19780822

Past, present and future directions in human genetic susceptibility to tuberculosis.

Marlo Möller1, Erika de Wit, Eileen G Hoal.   

Abstract

The historical impression that tuberculosis was an inherited disorder has come full circle and substantial evidence now exists of the human genetic contribution to susceptibility to tuberculosis. This evidence has come from several whole-genome linkage scans, and numerous case-control association studies where the candidate genes were derived from the genome screens, animal models and hypotheses pertaining to the disease pathways. Although many of the associated genes have not been validated in all studies, the list of those that have been is growing, and includes NRAMP1, IFNG, NOS2A, MBL, VDR and some TLR. Certain of these genes have consistently been associated with tuberculosis in diverse populations. The future investigation of susceptibility to tuberculosis is almost certain to include genome-wide association studies, admixture mapping and the search for rare variants and epigenetic mechanisms. The genetic identification of more vulnerable individuals is expected to inform personalized treatment and perhaps vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19780822     DOI: 10.1111/j.1574-695X.2009.00600.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  53 in total

1.  Infectious diseases not immune to genome-wide association.

Authors:  Paul I W de Bakker; Amalio Telenti
Journal:  Nat Genet       Date:  2010-09       Impact factor: 38.330

2.  Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.

Authors:  Emile R Chimusa; Noah Zaitlen; Michelle Daya; Marlo Möller; Paul D van Helden; Nicola J Mulder; Alkes L Price; Eileen G Hoal
Journal:  Hum Mol Genet       Date:  2013-09-20       Impact factor: 6.150

Review 3.  Old and new selective pressures on Mycobacterium tuberculosis.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Infect Genet Evol       Date:  2011-08-17       Impact factor: 3.342

Review 4.  Innate immune gene polymorphisms in tuberculosis.

Authors:  Abul K Azad; Wolfgang Sadee; Larry S Schlesinger
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

Review 5.  The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant.

Authors:  David G Russell
Journal:  Curr Opin Microbiol       Date:  2013-01-03       Impact factor: 7.934

6.  Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study.

Authors:  Allison R Baker; Sarah Zalwango; LaShaunda L Malone; Robert P Igo; Feiyou Qiu; Mary Nsereko; Mark D Adams; Pamela Supelak; Harriet Mayanja-Kizza; W Henry Boom; Catherine M Stein
Journal:  Hum Immunol       Date:  2011-02-25       Impact factor: 2.850

Review 7.  Infectious Diseases of Poverty in Children: A Tale of Two Worlds.

Authors:  Caitlin Hansen; Elijah Paintsil
Journal:  Pediatr Clin North Am       Date:  2016-02       Impact factor: 3.278

8.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

9.  Characterization of promoter of the tuberculosis-resistant gene intracellular pathogen resistance 1.

Authors:  Yongyan Wu; Fayang Liu; Yan Zhang; Yongsheng Wang; Zekun Guo; Yong Zhang
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

10.  Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients.

Authors:  Christina Thobakgale; Kewreshini Naidoo; Lyle R McKinnon; Lise Werner; Natasha Samsunder; Salim Abdool Karim; Thumbi Ndungʼu; Marcus Altfeld; Kogieleum Naidoo
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.